Quest Diagnostics
DGX
#1089
Rank
โ‚น1.473 T
Marketcap
โ‚น13,200
Share price
1.86%
Change (1 day)
17.03%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2023 (TTM): โ‚น557.67

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น573.87. In 2022 the company made an earnings per share (EPS) of โ‚น684.23 a decrease over its 2021 EPS that were of โ‚น1,347.

EPS history for Quest Diagnostics from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น557.67-18.5%
2022โ‚น684.23-49.21%
2021โ‚น1,34749.72%
2020โ‚น899.8666.67%
2019โ‚น539.9118%
2018โ‚น457.57-4.26%
2017โ‚น477.9423.19%
2016โ‚น387.96-7.11%
2015โ‚น417.6728.46%
2014โ‚น325.14-31.61%
2013โ‚น475.4060.46%
2012โ‚น296.27-16.51%
2011โ‚น354.852.45%
2010โ‚น346.364.35%
2009โ‚น331.9330.77%
2008โ‚น253.8368.93%
2007โ‚น150.26-40.6%
2006โ‚น252.989.96%
2005โ‚น230.0610.39%
2004โ‚น208.4116.35%
2003โ‚น179.1226.73%
2002โ‚น141.3590.29%
2001โ‚น74.2853.51%
2000โ‚น48.39-22900%
1999-โ‚น0.21-101.11%
1998โ‚น19.10-216.88%
1997-โ‚น16.34

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น638.39 11.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น28.96-105.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น78.10-113.61%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น79.80-113.91%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น123.45-78.49%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands